In other glomerulonephritides, such as lupus nephritis, ANCA-associated vasculitis nephritis or focal segmental glomerulosclerosis, urinary evidence of alternative pathway activation has also been reported in the literature, indicating that complement activation may not be unique to IgA-mediated kidney diseases [42–44]. This evidence concerns the gene CD79A and focal segmental glomerulosclerosis.